1-13 of 13
XueFeng He
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Venetoclax and Decitabine Compared with Standard Intensive Chemotherapy As Induction Therapy in Newly Diagnosed Acute Myeloid Leukemia: Updated Results of a Multicenter, Randomized, Phase 2b Trial

Jing Lu, Shengli Xue, Ying Wang, Xuefeng He, Xiaohui Hu, Miao Miao, Yang Zhang, Zaixiang Tang, Jundan Xie, Xiaofei Yang, Mingzhu Xu, Yaoyao Shen, Feng Du, Qian Vicky Wu, Mengxing Xue, Yun Wang, Ailing Deng, Xueqing Dou, Haiping Dai, Depei Wu, Suning Chen
Journal: Blood
Blood (2024) 144 (Supplement 1): 971.
https://doi.org/10.1182/blood-2024-202801
Published: 2024
Journal Articles

Short-Term Blinatumomab Prior to Allo-HSCT for High-Risk B-ALL

Huizhu Kang, Yuejun Liu, Ruju Wang, Meng Zhou, Chengyuan Gu, Xuefeng He, Jun Chen, Zhihong Lin, Depei Wu, Yue Han
Journal: Blood
Blood (2024) 144 (Supplement 1): 3494.
https://doi.org/10.1182/blood-2024-208142
Published: 2024
Journal Articles

Selective Histone Deacetylase Inhibitor Chidamide in Steroid Refractory Chronic Graft-Versus-Host Disease

Kangkang Lv, Yuejun Liu, Xuefeng He, Mingzhu Xu, Yuanyuan Du, Mimi Xu, Yue Han, Depei Wu
Journal: Blood
Blood (2024) 144 (Supplement 1): 7348.
https://doi.org/10.1182/blood-2024-209598
Published: 2024
Journal Articles

Improved Prevention and Treatment Strategy of Differentiation Syndrome Contribute to Reduce Early Death of Patients with Acute Promyelocytic Leukemia

Qian Wu, De-Pei Wu, Suning Chen, Xiaofei Yang, Jingren Zhang, Mengxing Xue, Xueqing Dou, Sheng-Li Xue, Huiying Qiu, Xiaowen Tang, Yue Han, Jianhong Fu, Xuefeng He
Journal: Blood
Blood (2023) 142 (Supplement 1): 1528.
https://doi.org/10.1182/blood-2023-182749
Published: 2023
Journal Articles

Comparing the Efficacy and Safety of Venetoclax Combined with Decitabine Versus Conventional Chemotherapy As Induction Therapy for Young Adults with Newly Diagnosed Acute Myeloid Leukemia - Interim Analysis of a Multicenter, Randomized, Phase 2b Trial

Jing Lu, Shengli Xue, Ying Wang, Hai-Ping Dai, Xuefeng He, Xiaohui Hu, Miao Miao, Huiying Qiu, Han Yue, Caixia Li, Depei Wu, Suning Chen
Journal: Blood
Blood (2023) 142 (Supplement 1): 970.
https://doi.org/10.1182/blood-2023-181347
Published: 2023
Journal Articles

Myelodysplastic Syndrome Associated Hemophagocytic Lymphohistiocytosis: A Retrospective Study of 15 Cases in a Single Center

Yue Song, Fei Zhou, Xiaoli Li, Ziyan Wang, Liyun Bai, Yifang Yao, Limin Liu, Xiao Ma, Suning Chen, Depei Wu, Xuefeng He
Journal: Blood
Blood (2023) 142 (Supplement 1): 1167.
https://doi.org/10.1182/blood-2023-173771
Published: 2023
Journal Articles

Venetoclax with decitabine as frontline treatment in younger adults with newly diagnosed ELN adverse-risk AML

Clinical Trials & Observations
Jundan Xie, Xiebing Bao, Sheng-Li Xue, Hongjie Shen, Jiannong Cen, Li Yao, Jinlan Pan, Mingqing Zhu, Dandan Liu, Xiaohui Hu, Qian Wu, Jingren Zhang, Haiping Dai, Yanglin Cao, Xuefeng He, Xiaowen Tang, Ai-Ning Sun, Ying Wang, Jianhong Fu, Huiying Qiu, Xiaofei Yang, Suning Chen, Depei Wu
Journal: Blood
Blood (2023) 142 (15): 1323–1327.
https://doi.org/10.1182/blood.2023020102
Published: 2023
Includes: Supplemental data
Journal Articles

Venetoclax Plus Decitabine for Young Adults with Newly Diagnosed ELN Adverse-Risk Acute Myeloid Leukemia: Updated Results of a Phase 2 Trial

Jundan Xie, Xiaofei Yang, Xiebing Bao, Hongjie Shen, Jiannong Cen, Li Yao, Xiaohui Hu, Qian Wu, Jingren Zhang, Xuefeng He, Xiaowen Tang, AiNing Sun, Hongchun Qiu, Shengli Xue, Ying Wang, Jianhong Fu, Huiying Qiu, Depei Wu, Suning Chen
Journal: Blood
Blood (2022) 140 (Supplement 1): 1439–1440.
https://doi.org/10.1182/blood-2022-166384
Published: 2022
Journal Articles

Low-Dose Decitabine Improves Platelet Recovery in Patients with Isolated Thrombocytopenia after HSCT

Yue Han, MD, Yaqiong Tang, Ying Zhao, Man Huang, Jia Chen, Jiaqian Qi, Ying Wang, Xiaojin Wu, Xiao Ma, Feng Chen, Xuefeng He, MD, Changgeng Ruan, MD PhD, Depei Wu, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3388.
https://doi.org/10.1182/blood.V128.22.3388.3388
Published: 2016
Journal Articles

EVI1 Expression Predicts Poor Survival in Acute Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation with Myeloblastic Conditioning

Xuefeng He, Suning Chen, MD PhD, Wu Depei, MD, Aining Sun
Journal: Blood
Blood (2014) 124 (21): 5308.
https://doi.org/10.1182/blood.V124.21.5308.5308
Published: 2014
Journal Articles

Refractory NK/T Cell Lymphoma Treated with Bortezomib+Chemotherapy and APBSCT.

Chengcheng Fu, Juan Wang, Xuefeng He, Ting Xu, Ri Zhang, MD, PhD, Wu Depei, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4602.
https://doi.org/10.1182/blood.V116.21.4602.4602
Published: 2010
Journal Articles

Atypical T Cell Prolymphocytic Leukemia – One Case Report

Xuefeng He, Wu Depei, MD, PhD, Xiao Ma, Yanan Zhou, Chengcheng Fu, Weiyang Li
Journal: Blood
Blood (2010) 116 (21): 4332.
https://doi.org/10.1182/blood.V116.21.4332.4332
Published: 2010
Journal Articles

Applying of Fludarabine in One Patient with CLL/PL Prolymphocytic Transformation - One Case Report.

XueFeng He, Ri Zhang, QinFen Ma, RuiFang Tao, DePei Wu
Journal: Blood
Blood (2005) 106 (11): 5035.
https://doi.org/10.1182/blood.V106.11.5035.5035
Published: 2005